Stockscreener 앱 받기
0.422
2.41%
-0.0104
시간 외 거래:
.41
-0.012
-2.84%
전일 마감가:
$0.4324
열려 있는:
$0.43505
하루 거래량:
428.21K
Relative Volume:
0.51
시가총액:
$9.10M
수익:
$414.60K
순이익/손실:
$-19.21M
주가수익비율:
-0.2604
EPS:
-1.6207
순현금흐름:
$-4.89M
1주 성능:
-3.45%
1개월 성능:
+1.44%
6개월 성능:
+24.12%
1년 성능:
-80.55%
1일 변동 폭
$0.41
$0.4398
1주일 범위
$0.4092
$0.4782
52주 변동 폭
$0.162
$2.75
Mangoceuticals Inc Stock (MGRX) Company Profile
명칭
Mangoceuticals Inc
전화
(833) 626-4679
주소
15110 DALLAS PKWY, SUITE 600, DALLAS
Compare MGRX vs VEEV, TEM, BTSG, HNGE, HQY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
0.422 | 9.10M | 414.60K | -19.21M | -4.89M | -1.6207 |
VEEV
Veeva Systems Inc
|
296.13 | 47.95B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
70.93 | 12.88B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
63.74 | 12.61B | 13.65B | 169.86M | 412.12M | 1.0758 |
HNGE
Hinge Health Inc
|
102.90 | 8.30B | 646.34M | -512.40M | 202.76M | -6.6871 |
HQY
Healthequity Inc
|
92.61 | 7.66B | 1.34B | 230.70M | 440.96M | 2.6695 |
Mangoceuticals Inc 주식(MGRX)의 최신 뉴스
Form 13D/A MANGOCEUTICALS For: 6 October By Investing.com - Investing.com South Africa
Form 13D/A MANGOCEUTICALS For: 6 October By Investing.com - Investing.com India
Form 13D/A MANGOCEUTICALS For: 6 October By Investing.com - Investing.com Canada
Form 4 Mangoceuticals Inc For: 6 October - Investing.com India
CFO receives 100,000 shares at Mangoceuticals (MGRX), holds 220,000 directly afterward. - Stock Titan
A CEO stock bonus is issuable instead of a change-of-control payment at Mangoceuticals (MGRX). - Stock Titan
With 1.63M option shares included, Mangoceuticals (MGRX) CEO reports his ownership stake. - Stock Titan
For board services, Mangoceuticals (MGRX) director Alex P. Hamilton received 100,000 shares. - Stock Titan
Mangoceuticals (MGRX) Shares Fall 12% After Hours: Here's Why - Benzinga
Mangoceuticals Announces $2.5 Million Subsidiary-Level Investment in MangoRx IP Holdings to Advance Antiviral Portfolio Commercialization - Quiver Quantitative
Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million Tranche - GlobeNewswire Inc.
Investors agreed to buy 25% of Mangoceuticals’ company holding antiviral patents for $2.5 million. - Stock Titan
Mangoceuticals Secures $2.5 Million Strategic Investment in - GlobeNewswire
Mangoceuticals Terminates Planned Business Combination with Nuclea - The Globe and Mail
Mangoceuticals Terminates Planned Business Combination with Nuclea - TipRanks
Mangoceuticals And Nuclea Energy Terminate Business Combination Agreement On August 19 - TradingView
Mangoceuticals Terminates Nuclea Energy Business Combination After $15 Million PIPE Not Secured - TradingView
Mangoceuticals Company Profile & Introduction - Moomoo
MGRX Stock Alert: Halper Sadeh LLC is Investigating Whether Mangoceuticals, Inc. is Obtaining a Fair Price for its Shareholders - businesswire.com
MANGOCEUTICALS, INC. Q2 2026: Revenue $68.76K, EPS $(0.09) — 10-Q Summary - TradingView
Mangoceuticals (MGRX) Q2 2026 loss shrinks while cash and revenue fall - Stock Titan
Mangoceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
12 Consumer Staples Stocks Moving In Thursday's After-Market Session - Benzinga
Mangoceuticals: Acquisition of Moltex Brings Advanced Nuclear R&D, Backed by More Than C$96M in Private Investment and Public Funding From Canada and the DOE >MGRX - Moomoo
Nuclea’s planned Moltex deal could add 80 nuclear patents - Stock Titan
MGRX Q3 2025 Earnings: -$0.69 Per Share Loss and 8.16% Stock Decline Highlight Ongoing ChallengesEarnings Yield Analysis - vinanet.vn
Why is Mangoceuticals stock surging today? - Investing.com India
On Thursday, there are stocks with unusual volume. Let's take a look. - ChartMill
Why is Mangoceuticals stock surging today? By Investing.com - Investing.com South Africa
Why is Mangoceuticals stock surging today? By Investing.com - Investing.com Nigeria
Mangoceuticals’ Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure - The Manila Times
Mangoceuticals' Merger Partner, Nuclea Energy Inc., Signs MOU With New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure - Moomoo
Why is Mangoceuticals stock surging today? By Investing.com - Investing.com Canada
Why is Mangoceuticals stock surging today? - Investing.com India
Mangoceuticals (MGRX) merger partner Nuclea inks Utah nuclear test reactor MOU - Stock Titan
Why is Mangoceuticals stock surging today? - Investing.com
Mangoceuticals (MGRX) Stock Jumps Over 49% After Hours: Here's Why - Benzinga
Mangoceuticals (MGRX) Stock Jumps Over 49% After Hours: Here's Why - TradingView
Mangoceuticals merger partner Nuclea signs MOU with New Mining on modular reactor power for data centers - Bitget
Mangoceuticals Wins Nasdaq Extension Amid Nuclea Deal Progress - The Globe and Mail
Wondering what's happening in today's after-hours session? - ChartMill
Mangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development - Yahoo Finance
Mangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development - GlobeNewswire
Mangoceuticals Wins Nasdaq Extension Amid Nuclea Deal Progress - TipRanks
Mangoceuticals (NASDAQ: MGRX) wins more time on Nasdaq rules, advances Nuclea deal - Stock Titan
Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination - The Manila Times
Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination - Yahoo Finance
Mangoceuticals Inc. (MGRX) Slides 15% to $0.45 as Selling Pressure IntensifiesSmart Money Flow Stocks - dars.gov.et
Mangoceuticals Inc. (MGRX) Slides 15% to $0.45 as Selling Pressure IntensifiesFactor ETF Flow - vinanet.vn
Mangoceuticals Granted 180-Day Extension by Nasdaq to - GlobeNewswire
Mangoceuticals Inc (MGRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Mangoceuticals Inc 주식 (MGRX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| JOHNSTON EUGENE M | CFO |
Dec 09 '25 |
Sale |
1.20 |
5,000 |
5,975 |
123,333 |
| JOHNSTON EUGENE M | CFO |
Dec 05 '25 |
Sale |
1.13 |
10,000 |
11,280 |
128,333 |
| JOHNSTON EUGENE M | Officer |
Dec 03 '25 |
Proposed Sale |
1.16 |
128,333 |
148,866 |
0 |
| Hamilton Alex P. | Director |
Nov 19 '25 |
Sale |
1.22 |
125,000 |
152,875 |
3,334 |
| Hamilton Alex P. | Director |
Nov 19 '25 |
Proposed Sale |
1.24 |
125,000 |
155,125 |
0 |
4.35%
0.63%
자본화:
|
볼륨(24시간):